Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials (Q77415822)
Jump to navigation
Jump to search
scientific article published on 01 September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials |
scientific article published on 01 September 1998 |
Statements
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials (English)
J B Whitmore
M G Kris
P J Hesketh
T H Grote
D M DuBois
M B Cramer
1 September 1998